Frontier Capital Management’s Procept Biorobotics PRCT Stock Holding History

Frontier Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.3M	Buy	609,857 +375,677	+160%	+$10.6M	0.16%	192
2025 Q4	$7.37M	Buy	234,180 +128,712	+122%	+$4.27M	0.08%	258
2025 Q3	$3.76M	Sell	105,468 -313,190	-75%	-$14.3M	0.03%	278
2025 Q2	$24.1M	Buy	418,658 +203,602	+95%	+$11.5M	0.22%	166
2025 Q1	$12.5M	Sell	215,056 -10,296	-5%	-$703K	0.14%	200
2024 Q4	$18.1M	Buy	+225,352	New	+$19.3M	0.17%	176

Other funds holding PRCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frontier Capital Management's PRCT Position: Q1 2026 in Review

Frontier Capital Management increased its Procept Biorobotics (PRCT) stake by 160% in Q1 2026, buying an estimated $10.6M and bringing the position to 609,857 shares worth $15.3M. The position accounts for 0.16% of the portfolio, ranked #192.

Frontier Capital Management first reported a position in PRCT in Q4 2024 and has held it in 6 quarters since. The position peaked at $24.1M in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

Frontier Capital Management held 609,857 shares of Procept Biorobotics worth $15.3M as of Q1 2026.
Frontier Capital Management bought 375,677 Procept Biorobotics shares in Q1 2026, an estimated $10.6M.
Procept Biorobotics made up 0.16% of Frontier Capital Management's portfolio in Q1 2026, its #192 holding.
Frontier Capital Management first reported a position in Procept Biorobotics in Q4 2024 and has held it in 6 quarters since.
Frontier Capital Management's Procept Biorobotics position peaked at $24.1M in Q2 2025.
256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.